OpenAlex
PricingAboutJobs
Log inGet started
Work

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Medical Research and Opinion
DOI: 10.1185/03007990802361499
Authors: Dagmar Kubitza, Michael Becka, Angelika Roth, Wolfgang Mueck
Institution: Bayer (Germany)
Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: rivaroxaban, factor Xa inhibitors, pharmacokinetics, pharmacodynamics, dose escalation, elderly subjects, bioavailability, anticoagulation, adverse events, prothrombin time, activated partial thromboplastin time, oral anticoagulants
SDG: Good health and well-being

Open Access status: closed

Funders: Bayer, Bayer HealthCare
OpenAlex ID: W1965492206
FWCI: 9.569
Cites: 37
Cited by: 277
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms